12 Einträge gefunden

1. Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE

   1. Goldschmidt, Hartmut
   2. Baertsch, Marc-Andrea
   3. Schlenzka, Jana
   4. Becker, Natalia
   5. Habermehl, Christina
   6. Hielscher, Thomas
   7. Raab, Marc-Steffen

   2021 - Forschungsinformationssystem des UKE
2. Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma

   1. Baertsch, Marc-Andrea
   2. Mai, Elias K
   3. Hielscher, Thomas
   4. Bertsch, Uta
   5. Salwender, Hans J
   6. Munder, Markus
   7. Fuhrmann, Stephan

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated

   1. Maas, Sybren L N
   2. Stichel, Damian
   3. Hielscher, Thomas
   4. Sievers, Philipp
   5. Berghoff, Anna S
   6. Schrimpf, Daniel
   7. Sill, Martin

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Response-adapted lenalidomide maintenance in newly diagnosed myeloma:results from the phase III GMMG-MM5 trial

   1. Goldschmidt, Hartmut
   2. Mai, Elias K
   3. Dürig, Jan
   4. Scheid, Christof
   5. Weisel, Katja C
   6. Kunz, Christina
   7. Bertsch, Uta

   2020 - Forschungsinformationssystem des UKE
5. CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

   1. Sievers, Philipp
   2. Hielscher, Thomas
   3. Schrimpf, Daniel
   4. Stichel, Damian
   5. Reuss, David E
   6. Berghoff, Anna S
   7. Neidert, Marian C

   2020 - Forschungsinformationssystem des UKE
6. Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma

   1. Merz, Maximilian
   2. Hielscher, Thomas
   3. Mai, Elias Karl
   4. Seckinger, Anja
   5. Hose, Dirk
   6. Jauch, Anna
   7. Sauer, Sandra

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
7. Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia

   1. van Tilburg, Cornelis M
   2. Milde, Till
   3. Witt, Ruth
   4. Ecker, Jonas
   5. Hielscher, Thomas
   6. Seitz, Angelika
   7. Schenk, Jens-Peter

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
8. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas

   1. Röhrich, Manuel
   2. Huang, Kristin
   3. Schrimpf, Daniel
   4. Albert, Nathalie L
   5. Hielscher, Thomas
   6. von Deimling, Andreas
   7. Schüller, Ulrich

   2018 - Forschungsinformationssystem des UKE
9. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

   1. Sahm, Felix
   2. Schrimpf, Daniel
   3. Stichel, Damian
   4. Jones, David T W
   5. Hielscher, Thomas
   6. Schefzyk, Sebastian
   7. Okonechnikov, Konstantin

   2017 - Forschungsinformationssystem des UKE
10. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

    1. Ramaswamy, Vijay
    2. Hielscher, Thomas
    3. Mack, Stephen C
    4. Lassaletta, Alvaro
    5. Lin, Tong
    6. Pajtler, Kristian W
    7. Jones, David T W

    2016 - Forschungsinformationssystem des UKE
11. Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma

    1. Remke, Marc
    2. Hering, Esther
    3. Gerber, Nicolas U
    4. Kool, Marcel
    5. Sturm, Dominik
    6. Rickert, Christian H
    7. Gerß, Joachim

    2013 - Forschungsinformationssystem des UKE
12. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.

    1. Remke, Marc
    2. Hielscher, Thomas
    3. Korshunov, Andrey
    4. Northcott, Paul A
    5. Bender, Sebastian
    6. Kool, Marcel
    7. Westermann, Frank

    2011 - Forschungsinformationssystem des UKE